9. Stryker
Kalamazoo, Mich.
2018 revenue: $13,600,000,000
R&D spend: $862,000,000
Employees: 36,000
Revenues/employee: $377,778
Fiscal year ending: Dec. 31, 2018
Last year’s rank: 10
Key Personnel:
Kevin Lobo, chairman & CEO; Michael Hutchinson, GC; Yin Becker, VP, communications, public affairs & strategic marketing; Bijoy Sagar, VP & CIO; Katherine Owen, VP, strategy & IR; Lonny Carpenter, president, global quality & business operations; Kathryn Fink, VP, HR; David Floyd, president, orthopedics; Timothy Scannell, president, MedSurg & neurotechnology; William Jellison, VP & CFO
Description:
The world’s largest orthopedic device company is enjoying strong momentum this year, after a 2018 in which its bottom line more than tripled to $3.6 billion and sales grew 9.3% to $13.6 billion. Stryker (NYSE:SYK) officials see the company bolstering its position in the spine market as it integrates K2M, which the company acquired for about $1.4 billion in November 2018. Demand also remains high for Stryker’s Mako systems for robot-assisted knee and hip surgery. SVB Leerink analysts wrote during the AAOS annual meeting in March that Mako remains best-in-class in an expanding category. Stryker this month announced it would further bolster its early position in robotics with a $500 million all-cash bid for Mobius Imaging and its Cardan Robotics subsidiary. – CN